1,1-Diheterocyclic Ethylenes Derived from Quinaldine and Carbazole as New Tubulin-Polymerization Inhibitors: Synthesis, Metabolism, and Biological Evaluation
- 10 December 2018
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 62 (4) , 1902-1916
Abstract
We report the synthesis, metabolism and biological evaluation of a series of 17 novel heterocyclic derivatives of isoCombretastatin-A4 and their structure-activity relationship. Among these derivatives, the most active compound 4f inhibited the growth of a panel of seven cancer cell lines with an IC50 in the low nanomolar range. In addition, 4f showed interesting activity against CA-4-resistant colon carcinoma cells and multidrug-resistant leukemia cells. It also induced G2/M cell cycle arrest. Structural data indicated binding of 4f to the colchicine site of tubulin, likely preventing the curved-to-straight tubulin structural changes that occur during microtubule assembly. Also, 4f disrupted the blood vessel-like assembly formed by human umbilical vein endothelial cells in vitro, suggesting its function as vascular disrupting agent. In vitro metabolism study of 4f showed its high human microsomal stability in comparison to isoCA-4. The physicochemical properties of 4f may be conducive to CNS permeability suggesting that this compound may be a possible candidate for the treatment of glioblastoma.Keywords
Funding Information
- Agence Nationale de la Recherche
- Fondation ARC pour la Recherche sur le Cancer
- Ligue Contre le Cancer
- Centre National de la Recherche Scientifique
- Universit? Paris-Sud
This publication has 57 references indexed in Scilit:
- Conformationnally restricted naphthalene derivatives type isocombretastatin A-4 and isoerianin analogues: Synthesis, cytotoxicity and antitubulin activityEuropean Journal of Medicinal Chemistry, 2012
- Cardiovascular Toxicity Profiles of Vascular-Disrupting AgentsThe Oncologist, 2011
- Synthesis and Antitumor Activity of 1,5-Disubstituted 1,2,4-Triazoles as Cis-Restricted Combretastatin AnaloguesJournal of Medicinal Chemistry, 2010
- A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancerBritish Journal of Cancer, 2010
- Features and development of CootActa Crystallographica Section D Structural Biology, 2010
- XDSActa Crystallographica Section D Structural Biology, 2010
- Synthesis, Biological Evaluation of 1,1‐Diarylethylenes as a Novel Class of Antimitotic AgentsChemMedChem, 2009
- Structural Plasticity in Actin and Tubulin Polymer DynamicsScience, 2009
- Variations in the colchicine-binding domain provide insight into the structural switch of tubulinProceedings of the National Academy of Sciences, 2009
- Phasercrystallographic softwareJournal of Applied Crystallography, 2007